Cilofungin
From Wikipedia, the free encyclopedia
| Cilofungin | |
|---|---|
 |
|
|
N-[(11R,20R,21R,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis(1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-(octyloxy)benzamide |
|
| Identifiers | |
| CAS number | 79404-91-4 |
| PubChem | 71762 |
| UNII | 8ZJC54A39X  |
| MeSH | Cilofungin |
| Properties | |
| Molecular formula | C49H71N7O17 |
| Molar mass | 1030.12 g mol−1 |
 (verify) (what is:  / ?)Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Cilofungin is the first clinically applied member of the Echinocandin family of antifungal drug. It was derived from a fungus in the genus Aspergillus. It accomplishes this by interfering with an invading fungus' ability to synthesize the cell wall (specifically, it inhibits the conversion of lanosterol to ergosterol).[1]
[edit] References
- ^ Hudler, George (1998). Magical Mushrooms, Mischievous Molds. Princeton, New Jersey: Princeton University Press. pp. 112. ISBN 978-0-691-07016-2.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
